Clinical Trial Update: Ayahuasca and Esketamine for Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ayahuasca and esketamine for severe major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ayahuasca (ayahuasca (psychedelic brew containing N,N-dimethyltryptamine and beta-carbolines))
• Esketamine (esketamine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Major Depression Severe | Phase 2 | Status: COMPLETED